Impel Pharmaceuticals Inc (IMPLQ)

Impel Pharmaceuticals Revenue

Impel Pharmaceuticals had revenue of $5.02M in the quarter ending September 30, 2023, with 62.98% growth. This brings the company's revenue in the last twelve months to $20.99M, up 155.29% year-over-year. In the year 2022, Impel Pharmaceuticals had annual revenue of $12.65M with 1,794.01% growth.

• Revenue (ttm): $20.99M
• Revenue Growth: +155.29%
• P/S Ratio: 0.02
• Revenue / Employee: $131,169
• Employees: 160
• Market Cap: 356.24K

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2022	12.65M	11.98M	1,794.01%
Dec 31, 2021	668.00K	-	-
Dec 31, 2020	0	-	-
Dec 31, 2019	0	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.